← back to search

Wendy A. Keitel

Baylor College of Medicine · US
Area of research
Epidemiology · Infectious Diseases
Research interest
Research interests include Influenza Virus Research Studies, Respiratory viral infections research, SARS-CoV-2 and COVID-19 Research, and Immune Response and Inflammation.
h-index
37
citations
19,964
works
129
NIH funding
primary concept
email

Recent publications

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial
Nature Medicine 2023cited by 54position: middledoi
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants
npj Vaccines 2023cited by 32position: middledoi
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant
Cell Reports Medicine 2022cited by 167position: middledoi
Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial
The Lancet Infectious Diseases 2022cited by 25position: middledoi
Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019
MMWR Recommendations and Reports 2019cited by 123position: middledoi
Clinical, Virologic, and Immunologic Characteristics of Zika Virus Infection in a Cohort of US Patients: Prolonged RNA Detection in Whole Blood
Open Forum Infectious Diseases 2018cited by 33position: middledoi
Tularemia vaccine: Safety, reactogenicity, “Take” skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain – A phase 2 randomized clinical Trial
Vaccine 2017cited by 37position: middledoi
Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial
Vaccine 2017cited by 26position: middledoi
Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects
Vaccine 2015cited by 148position: middledoi
Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response
JAMA 2015cited by 138position: middledoi
Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human clinical trial
Vaccine 2014cited by 27position: middledoi
Safety of Zoster Vaccine in Elderly Adults Following Documented Herpes Zoster
The Journal of Infectious Diseases 2013cited by 44position: middledoi
Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: A randomized trial
Vaccine 2013cited by 39position: middledoi
The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters
The FASEB Journal 2012cited by 392position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Robert L. Atmar · Baylor College of Medicine6 papers (2015–2019)Hana M. El Sahly · Baylor College of Medicine6 papers (2013–2018)Shital M. Patel · Baylor College of Medicine6 papers (2012–2018)Nadine Rouphael · Emory University4 papers (2015–2018) · 4 papers (2015–2017)Mark J. Mulligan · NYU Langone Health4 papers (2015–2018)Sharon E. Frey · Griffith University4 papers (2015–2017)Edwin L. Anderson · Boston Children's Museum4 papers (2015–2017) · 4 papers (2015–2017)Harry Keyserling · Emory University3 papers (2013–2015)Srilatha Edupuganti · Emory University3 papers (2015–2018)Patricia Winokur · University of Iowa3 papers (2015–2017)Johannes B. Goll · Emmes (United States)3 papers (2015–2017)James D. Campbell · University of Missouri2 papers (2015–2017) · 2 papers (2013–2019)Charles E. Rose · Sandia National Laboratories2 papers (2013–2014)Jack T. Stapleton · University of Iowa2 papers (2015–2017)Samer S. El‐Kamary · Novartis (Switzerland)2 papers (2015–2017)Karen L. Kotloff · MRC Unit the Gambia2 papers (2015–2017)Robert M. Jacobson · Medical College of Wisconsin2 papers (2013–2014)